Clinical Trials on ASD Accompanied by Moderate to Severe Gastrointestinal Symptoms
Total 4570 results
-
Xinhua Hospital, Shanghai Jiao Tong University...TerminatedASD Accompanied by Moderate to Severe Gastrointestinal SymptomsChina
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
PfizerCompleted
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
Merck Sharp & Dohme LLCTerminatedWomen | Moderate to Severe Vasomotor Symptoms in Postmenopausal
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Janssen PharmaceuticaWithdrawnModerate to Severe Acute Non-Cancer Pain
-
AbbViePivotal S.L.; Laboratorio EchevarneCompletedModerate to Severe Crohn's Disease
-
Light Chain Bioscience - Novimmune SACompletedModerate to Severe Crohn's Disease
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
Janssen PharmaceuticaWithdrawnModerate to Severe Chronic Non-cancer Pain
-
Mundipharma Research GmbH & Co KGCompletedSubjects With Moderate to Severe, Chronic Nonmalignant Pain
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedModerate to Severe AsthmaAustralia
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
IpsenRecruitingModerate to Severe Upper Facial LinesGermany, France
-
NovartisCompletedModerate to Severe HypertensionRussian Federation, Romania, Singapore, Spain, Germany, Philippines
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Wake Forest University Health SciencesCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedModerate to Severe PsoriasisSwitzerland
-
Merck KGaA, Darmstadt, GermanyCompletedModerate to Severe PsoriasisSwitzerland
-
PfizerCompletedModerate to Severe PsoriasisKorea, Republic of
-
Shanghai Junshi Bioscience Co., Ltd.CompletedModerate to Severe PsoriasisChina
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
Hospital Universitari Son DuretaEspen; This research prize was funded by Nestle Nutrition Institute and by...CompletedModerate to Severe Trauma, as Defined by an | Injury Severity Score (ISS) > 12 Points Were Included in the Study.Spain
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Idiopathic RLS With Daytime SymptomsSpain, Sweden, Germany
-
AstraZenecaJohnson & JohnsonCompletedSedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic PolypectomyJapan
-
GC Cell CorporationRecruitingClinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With PsoriasisModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
BiocadCompleted
-
AbbVieCompleted
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisRussian Federation
-
Kyowa Kirin Co., Ltd.Completed
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingModerate-to-Severe Plaque PsoriasisChina
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingModerate to Severe Plaque PsoriasisChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingModerate-to-Severe Plaque Psoriasis
-
Sun Pharmaceutical Industries LimitedRecruitingModerate to Severe Plaque PsoriasisUnited States, El Salvador
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdActive, not recruitingModerate-to-Severe Plaque PsoriasisChina
-
Hangzhou Highlightll Pharmaceutical Co., LtdCompletedModerate to Severe Plaque PsoriasisChina
-
Samsung Bioepis Co., Ltd.CompletedPsoriasis | Moderate to Severe Plaque PsoriasisCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Lithuania, Poland, Ukraine
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.WithdrawnModerate to Severe Plaque PsoriasisChina
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
UCB Biopharma SRLNot yet recruiting
-
Bristol-Myers SquibbNot yet recruitingModerate-to-severe Plaque PsoriasisKorea, Republic of
-
Novartis PharmaceuticalsRecruitingModerate-to-severe Plaque PsoriasisRussian Federation
-
Kyowa Kirin Korea Co., Ltd.CompletedModerate to Severe Plaque PsoriasisKorea, Republic of